Form 4: STE director Martin Paul Edward receives vested options and Career RSUs

Rhea-AI Filing Summary

Martin Paul Edward, a director of STERIS plc (STE), reported equity awards on 08/08/2025: he received 1,407 nonqualified stock options with an exercise price of $242.85 and an expiration date of 08/08/2035. The filing states those options are fully vested and exercisable immediately. He also acquired 487 Career Restricted Stock Units (RSUs) that are fully vested and will be settled into ordinary shares six months after he ceases Board service. After these transactions the Form 4 lists 1,407 options and 4,562 RSUs as the amounts beneficially owned following the reported transactions. The form was signed by an authorized representative on 08/12/2025.

This disclosure is a routine Section 16 filing showing director compensation in equity form, with clear vesting and settlement mechanics described for the RSUs and immediate exercisability for the options.

Positive

• 1,407 nonqualified stock options were granted and are fully vested and exercisable immediately, increasing the director's direct option holdings.
• 487 Career Restricted Stock Units were granted and are fully vested, with settlement mechanics (six months after cessation of Board service) clearly disclosed.

Negative

• None.

Insights

Securities Analyst

TL;DR: Director received vested options and RSUs, increasing direct equity exposure; transaction is a standard director award, not an open-market purchase.

The Form 4 documents an 08/08/2025 grant to Director Martin Paul Edward of 1,407 nonqualified stock options at a $242.85 exercise price and 487 Career RSUs. The options are fully vested and exercisable immediately and expire 08/08/2035. The Career RSUs are fully vested but will be settled six months after cessation of Board service, which affects timing of share delivery. This is a compensation-related issuance rather than a market trade, so short-term price signal is limited, while long-term ownership alignment is evident.

Corporate Governance Expert

TL;DR: Compensation disclosure is clear on vesting and settlement; governance impact centers on retention-focused Career RSUs with post-service settlement timing.

The filing clarifies that Career RSUs vest immediately but convert to shares only six months after the director leaves the Board, a common retention and post-service alignment mechanism. The immediate exercisability of the options is explicitly stated in the explanation. Both features are documented on the Form 4 and align a director's economic interest with shareholders while prescribing delayed settlement for the RSUs. No departures, amendments, or unusual transfer codes are present in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Martin Paul Edward

(Last) (First) (Middle)

C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 L2 D02 R296

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (right to buy)	$242.85	08/08/2025		A		1,407		(1)	08/08/2035	Ordinary Shares	1,407	$0	1,407	D
Career Restricted Stock Units	(2)	08/08/2025		A		487		(3)	(3)	Ordinary Shares	487	$0	4,562	D

Explanation of Responses:

1. These nonqualified stock options are fully vested and are exercisable immediately.

2. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

3. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the STERIS (STE) Form 4 filed on 08/12/2025 disclose?

The filing reports that director Martin Paul Edward acquired 1,407 stock options and 487 Career RSUs on 08/08/2025.

What is the exercise price and expiration for the options reported by STE director?

The reported nonqualified stock options have an exercise price of $242.85 and an expiration date of 08/08/2035.

Are the options and RSUs vested according to the Form 4 for STE?

Yes. The Form 4 states the options are fully vested and exercisable immediately and the Career RSUs are fully vested immediately.

When will the Career RSUs reported for STE be settled into shares?

Each Career RSU will be settled in ordinary shares six months after the cessation of the director's Board service.

How many derivative securities does the Form 4 list as beneficially owned after the transaction?

The form lists 1,407 options beneficially owned following the transaction and 4,562 RSUs as the number of RSUs beneficially owned following the reported transactions.

Who signed the Form 4 for STE and when was it signed?

The Form 4 was signed by authorized representative John P. Ubbing on 08/12/2025.